Soma Pharmacy Blognews

Parks, Green Spaces Protect Your Health
There is more evidence that living near parks, woods, or other green spaces may improve your mental and physical health.

Late-Dementia Suffering Often Unnecessary
Patients with advanced Alzheimer’s disease or other age-related dementias often suffer unnecessarily near the end of life probably because their condition is not recognized as fatal, researchers say.

U.S. Pregnancy Rate Is Dropping
The U.S. pregnancy rate dropped by 11% from 1990 to 2005, a new CDC report shows.

No Link Between Bypass Surgery, Memory Loss
Despite earlier reports to the contrary, having bypass surgery to help your heart does not harm your brain, researchers report.

Nuts, Vegetables, Fish Cut Alzheimer’s Risk
A diet rich in cruciferous and green leafy vegetables, nuts, fish, and tomatoes and low in red meat and high-fat dairy products may protect against Alzheimer’s disease, a study suggests.

New market research report on global generic industry landscape
Research and Markets (http://www.researchandmarkets.com/research/3e7026/partnering_in_the) has announced the addition of the “Partnering in the Global Generics Industry 2009: A Guide to Companies” report to their offering.

Progenics Pharmaceuticals and Wyeth Pharmaceuticals sign license agreement
Progenics Pharmaceuticals, Inc. today announced that it has entered into an agreement with Wyeth Pharmaceuticals, a division of Wyeth under which Progenics is regaining all worldwide rights to the RELISTOR® franchise from Wyeth Pharmaceuticals, which Progenics had previously licensed to Wyeth Pharmaceuticals.

Mylan Pharmaceuticals and Matrix Laboratories enter into license agreement relating to Voriconazole Tablets
Mylan Inc. today announced that the company’s Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer’s Vfend® Tablets, a triazole antifungal agent.

Experts to discuss the safety of H1N1 flu vaccine
The U.S. Department of Health and Human Services (HHS) will host a Know What to Do about the Flu Webcast on Wednesday, October 14.

Presentation on L-DOS47 drug formulation and development at Pharmaceutical Industry Conference
Helix BioPharma Corp. (TSX, FSE: “HBP” / OTCQX: HXBPF) today announced that a presentation on L-DOS47 formulation and analytical method development will be made at the “Formulation Strategies for Protein Therapeutics” conference to be held on October 13 to 15, 2009, in Raleigh, North Carolina. [...]